Bumrungrad Hospital Valuation
Is BH-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BH-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BH-R (THB245) is trading above our estimate of fair value (THB167.28)
Significantly Below Fair Value: BH-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BH-R?
Other financial metrics that can be useful for relative valuation.
What is BH-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿194.75b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 7x |
Enterprise Value/EBITDA | 18.5x |
PEG Ratio | 6.6x |
Price to Earnings Ratio vs Peers
How does BH-R's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 28.7x | ||
BDMS Bangkok Dusit Medical Services | 29.4x | 7.4% | ฿441.0b |
BCH Bangkok Chain Hospital | 33.4x | 16.1% | ฿49.1b |
VIBHA Vibhavadi Medical Center | 30x | n/a | ฿29.8b |
RAM Ramkhamhaeng Hospital | 22.1x | 5.2% | ฿36.0b |
BH-R Bumrungrad Hospital | 26.3x | 4.0% | ฿194.8b |
Price-To-Earnings vs Peers: BH-R is good value based on its Price-To-Earnings Ratio (26.3x) compared to the peer average (28.7x).
Price to Earnings Ratio vs Industry
How does BH-R's PE Ratio compare vs other companies in the TH Healthcare Industry?
Price-To-Earnings vs Industry: BH-R is expensive based on its Price-To-Earnings Ratio (26.3x) compared to the TH Healthcare industry average (26x).
Price to Earnings Ratio vs Fair Ratio
What is BH-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 26.3x |
Fair PE Ratio | 30.2x |
Price-To-Earnings vs Fair Ratio: BH-R is good value based on its Price-To-Earnings Ratio (26.3x) compared to the estimated Fair Price-To-Earnings Ratio (30.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.